The Chemours Price Target, Predictions & Analyst Ratings

$29.75
-0.98 (-3.19 %)
(As of 09/17/2021 12:00 AM ET)
Add
Compare
Today's Range
$29.56
$30.64
50-Day Range
$29.75
$34.88
52-Week Range
$19.36
$38.87
Volume3.12 million shs
Average Volume938,895 shs
Market Capitalization$4.91 billion
P/E Ratio19.44
Dividend Yield3.25%
Beta2.14

The Chemours (NYSE:CC) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analyst Rating Consensus

Buy
Based on 9 Analyst Ratings

Analyst Price Target Consensus

$37.78

High PT$48.00
Average PT$37.78
Low PT$28.00
TypeCurrent
9/18/20 to 9/18/21
1 Month Ago
8/19/20 to 8/19/21
3 Months Ago
6/20/20 to 6/20/21
1 Year Ago
9/19/19 to 9/18/20
Consensus Rating
Buy
Buy
Buy
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
7 Buy rating(s)
7 Buy rating(s)
7 Buy rating(s)
2 Buy rating(s)
Hold
2 Hold rating(s)
2 Hold rating(s)
4 Hold rating(s)
8 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$37.78$37.78$34.00$16.60
Price Target Upside26.98% Upside18.89% Upside21.77% Upside15.85% Upside
Get The Chemours Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CC and its competitors with MarketBeat's FREE daily newsletter.


Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

The Chemours (NYSE:CC) vs. Its Competitors

TypeThe ChemoursBasic Materials CompaniesS&P 500
Consensus Rating Score
2.78
2.63
2.56
Consensus RatingBuyBuyBuy
Price Target Upside88.42% Upside8.36% Upside
News Sentiment RatingPositive News
Neutral News
Neutral News
MarketBeat
Community Rating
Outperform Votes
606
63.92%
Underperform Votes
342
36.08%
Avg. Outperform Votes
131
63.29%
Avg. Underperform Votes
76
36.71%
Avg. Outperform Votes
829
69.55%
Avg. Underperform Votes
363
30.45%

The Chemours (NYSE:CC) Analyst Ratings History

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
8/3/2021Royal Bank of Canada
Boost Price TargetOutperform$35.00 ➝ $40.00+19.37%
6/30/2021BMO Capital Markets
Boost Price TargetOutperform$42.00 ➝ $48.00+38.61%
6/9/2021Wolfe Research
Initiated CoverageOutperform
6/9/2021The Goldman Sachs Group
UpgradeNeutral ➝ Buy$35.00 ➝ $47.00+27.65%
5/20/2021Bank of America
Initiated CoverageBuy$42.00+26.43%
5/10/2021Morgan Stanley
Boost Price TargetEqual Weight$30.00 ➝ $35.00+1.07%
5/6/2021Argus
UpgradeHold ➝ Buy$40.00+18.41%
2/17/2021Citigroup
Boost Price Target$27.00 ➝ $29.00+11.37%
12/4/2020Barclays
DowngradeOverweight ➝ Equal Weight$26.00 ➝ $28.00+8.99%
11/30/2020Alembic Global Advisors
Initiated CoverageOverweight$31.00+25.10%
7/9/2020UBS Group
Boost Price TargetNeutral$12.00 ➝ $15.00-5.12%
5/7/2020SunTrust Banks
Boost Price TargetHold$10.00 ➝ $12.00+2.21%
4/14/2020Susquehanna Bancshares
Lower Price Target$23.00 ➝ $17.00+51.11%
4/3/2020Cfra
Lower Price TargetStrong-Buy ➝ Hold$21.00 ➝ $11.00+49.25%
3/23/2020Jefferies Financial Group
DowngradeBuy ➝ Hold
12/20/2019JPMorgan Chase & Co.
Lower Price TargetNeutral$21.00 ➝ $19.00+3.66%
1/8/2019HSBC
Initiated CoverageBuy ➝ Buy$52.00+55.18%
(Data available from 9/18/2016 forward. View 10+ years of historical ratings with our analyst ratings screener.)
speech bubbles
speech bubbles











The Chemours (NYSE:CC) Analyst Ratings Frequently Asked Questions

What is The Chemours's consensus rating and price target?

According to the issued ratings of 9 analysts in the last year, the consensus rating for The Chemours stock is Buy based on the current 2 hold ratings and 7 buy ratings for CC. The average twelve-month price target for The Chemours is $37.78 with a high price target of $48.00 and a low price target of $28.00. Learn more on CC's analyst rating history

Do Wall Street analysts like The Chemours more than its competitors?

Analysts like The Chemours stock more than the stock of other Basic Materials companies. The consensus rating score for The Chemours is 2.78 while the average consensus rating score for basic materials companies is 2.63. Learn more on how CC compares to other companies

Do MarketBeat users like The Chemours more than its competitors?

MarketBeat users like The Chemours stock more than the stock of other Basic Materials companies. 63.92% of MarketBeat users gave The Chemours an outperform vote while basic materials companies recieve an average of 63.29% outperform votes by MarketBeat users.

Does The Chemours's stock price have much upside?

According to analysts, The Chemours's stock has a predicted upside of 18.89% based on their 12-month price targets.

What analysts cover The Chemours?

The Chemours has been rated by BMO Capital Markets, and Royal Bank of Canada in the past 90 days.

This page was last updated on 9/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.